Spyre Therapeutics, Inc.
HealthcareNASDAQ:SYRE · NASDAQ Capital Market
+$0.02 today
Vol 0.79M · Avg 1.16M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+367.26%
Period High
$80.79
Period Low
$14.68
Latest
$80.79
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Pharvaris N.V.
NASDAQ:PHVS
$2.15B
Celldex Therapeutics, Inc.
NASDAQ:CLDX
$2.08B
Immunome, Inc.
NASDAQ:IMNM
$1.76B
Zymeworks Inc.
NASDAQ:ZYME
$1.68B
AbCellera Biologics Inc.
NASDAQ:ABCL
$1.60B
Ardelyx, Inc.
NASDAQ:ARDX
$1.41B
Intellia Therapeutics, Inc.
NASDAQ:NTLA
$1.36B
Maze Therapeutics, Inc.
NASDAQ:MAZE
$1.33B
Wave Life Sciences Ltd.
NASDAQ:WVE
$1.13B
Upstream Bio, Inc.
UPB
$331.96M
What is the latest SYRE filing?
The latest filing shown is 4 dated Jun 3, 2026.
How many recent filings does SYRE have?
Intrinsic Alpha currently shows 20 recent filings for SYRE.
Explore More
Continue the stock analysis
Jump to another research area for this company.